Publicaciones (25) Publicaciones de Ines González Suarez

2024

  1. Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks

    Neurology, Vol. 103, Núm. 6

  2. Multiple sclerosis: Pregnancy, fertility, and assisted reproductive technology–a review

    Multiple Sclerosis and Related Disorders, Vol. 92

2023

  1. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

    Multiple Sclerosis and Related Disorders, Vol. 75

  2. Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel

    Neurology and Therapy, Vol. 12, Núm. 2, pp. 427-439

  3. People with Primary Progressive Multiple Sclerosis Have a Lower Number of Central Memory T Cells and HLA-DR+ Tregs

    Cells, Vol. 12, Núm. 3, pp. 439

  4. Real-world persistence to first-line DMTs in relapsing-remitting multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 78

  5. Reliability, validity and distribution of the Spanish female sexual function index in women with relapsing multiple sclerosis

    BMC Women's Health, Vol. 23, Núm. 1

  6. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  7. Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in Immunology, Vol. 14

  8. Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience

    Frontiers in Neurology, Vol. 14

2022

  1. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

  2. Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder

    Journal of Personalized Medicine, Vol. 12, Núm. 5

  3. Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients

    PLoS ONE, Vol. 17, Núm. 5 May

  4. Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study

    Neurology and Therapy, Vol. 11, Núm. 3, pp. 1101-1116

2021

  1. Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 8, Núm. 2

  2. Non-inflammatory causes of emergency consultation in patients with multiple sclerosis

    Neurologia, Vol. 36, Núm. 6, pp. 403-411

  3. Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review

    Multiple Sclerosis and Related Disorders, Vol. 49

  4. Quantifying the patient's perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire

    PLoS ONE, Vol. 16, Núm. 7 July

2017

  1. Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation

    Brain and Behavior, Vol. 7, Núm. 4

  2. Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 18, pp. 71-76